Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies EA Lutz, Y Agarwal, N Momin, SC Cowles, JR Palmeri, E Duong, V Hornet, ... Proceedings of the National Academy of Sciences 119 (36), e2205983119, 2022 | 18 | 2022 |
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies BM Lax, JR Palmeri, EA Lutz, A Sheen, JA Stinson, L Duhamel, ... Proceedings of the National Academy of Sciences 120 (31), e2300895120, 2023 | 8 | 2023 |
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy SC Cowles, A Sheen, L Santollani, EA Lutz, BM Lax, JR Palmeri, ... MAbs 14 (1), 2088454, 2022 | 8 | 2022 |
Yeast surface display for protein engineering: library generation, screening, and affinity maturation BH Kang, BM Lax, KD Wittrup Yeast Surface Display, 29-62, 2022 | 5 | 2022 |
Tregs constrain CD8+ T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy JR Palmeri, BM Lax, JM Peters, L Duhamel, JA Stinson, L Santollani, ... Biorxiv, 2023 | 2 | 2023 |
CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs JR Palmeri, BM Lax, JM Peters, L Duhamel, JA Stinson, L Santollani, ... Nature Communications 15 (1), 1900, 2024 | 1 | 2024 |
Mechanistic Elucidation and Therapeutic Improvement of Anti-CTLA-4 Therapies BM Lax Massachusetts Institute of Technology, 2023 | | 2023 |
Correction to: Yeast Surface Display for Protein Engineering: Library Generation, Screening, and Affinity Maturation BH Kang, BM Lax, KD Wittrup Yeast Surface Display, C1-C1, 2022 | | 2022 |